Bio-Rad’s S3™ Cell Sorter Chosen for Annual Course in Flow Cytometry


Prof. David Galbraith of the University of Arizona, a renowned expert in cytometry instrumentation, will lead the Fluorescent Protein Analysis and Sorting session.

Hercules, CA — June 8, 2013 — Bio-Rad’s S3 cell sorter will be used as a training instrument at the 36th Annual Research Course in Flow Cytometry, held at the University of New Mexico June 8–14, 2013.

“We chose the S3 cell sorter because it represents one example of an emerging trend in flow cytometric instrumentation, encompassing automated setup and operation as a sorter, a drastically reduced capital cost, and an accompanying small laboratory footprint,” said Dr. David Galbraith, co-director, with Teresa Hawley, of the Fluorescent Protein Analysis and Sorting lab session.

The research methods course will be offered with an emphasis on applications in cell biology, immunology, cell labeling, fluorescent protein analysis, bead-based assays, screening, and sorting. Distinguished members of the flow cytometry community will teach a number of laboratory sessions and lectures aimed at individuals with some experience in flow cytometry. Participants include students, postdocs, technicians, junior faculty, and company technical representatives. All attendees will have access to a wide variety of commercial and developmental instruments.

“I anticipate many applications will emerge as a result of moving flow cytometry and cell sorting into user laboratories and away from central cores,” said Galbraith. “Nevertheless, for some activities, core facilities will remain indispensible. I want attendees to be aware of these considerations, and to appreciate the capabilities of the new-generation instruments like the S3 cell sorter.”

The Annual Research Course in Flow Cytometry is the longest-running flow cytometry training course in the U.S. It alternates between Bowdoin College in Maine and the University of New Mexico at Albuquerque.

For more information about the S3 cell sorter, please visit

About the S3 Cell Sorter
The S3 cell sorter is an automated, easy-to-use, benchtop cell sorter equipped with one or two lasers, forward- and side-scatter detectors, and up to four fluorescent detectors. The S3 cell sorter and its ProSort™ software were designed to enable even novices to set up and calibrate the instrument in less than 30 minutes with minimal user input. Automated system monitoring features create a “walk-away” capability during the sort process. The simplicity of operation and the price point of the S3 cell sorter make cell sorting more accessible to new labs and core facilities that previously could not afford or support a flow cytometry instrument.

About Bio-Rad
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) has been at the center of scientific discovery for 60 years, manufacturing and distributing a broad range of products for life science research and clinical diagnostic markets. The company is renowned for its commitment to quality and customer service among university and research institutions, hospitals, public health and commercial laboratories, as well as the biotechnology, pharmaceutical, and food safety industries. Founded in 1952, Bio-Rad is based in Hercules, California, and serves more than 100,000 research and industry customers through its global network of operations. The company employs approximately 7,300 people worldwide and had revenues exceeding $2 billion in 2012. Visit us at

This release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements generally can be identified by the use of forward-looking terminology such as, “believe,” “expect,” “may,” “will,” “intend,” “estimate,” “continue,” or similar expressions or the negative of those terms or expressions. Such statements involve risks and uncertainties, which could cause actual results to vary materially from those expressed in or indicated by the forward-looking statements. For further information regarding the Company's risks and uncertainties, please refer to the “Risk Factors” in the Company’s public reports filed with the Securities and Exchange Commission, including the Company’s most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. The Company cautions you not to place undue reliance on forward-looking statements, which reflect an analysis only and speak only as of the date hereof. Bio-Rad Laboratories, Inc., disclaims any obligation to update these forward-looking statements.

For more information contact:
Steve Kulisch
Bio-Rad Laboratories, Inc.

Ken Li
Chempetitive Group
312-997-2436 x 112